Single-center perioperative management and 1-year heart transplantation outcomes for patients with adult congenital heart disease
Reice Robinson(University of California San Diego), Marcus A. Urey(University of California San Diego), Sarah Ellis(University of San Diego), Victor Pretorius(University of California San Diego), Angela Meier(University of San Diego), A. Kafi(University of California System), Kamyar Afshar(University of California San Diego), Irine Vodkin(University of California San Diego), Veeral Ajmera(University of California San Diego), Matthew Carazo(Emory University), Mark Kearns(University of California San Diego), Gabriel T. Schnickel(University of California San Diego), Samvel Gaboyan(University of California System), Kimberly N. Hong(University of California San Diego), Ryan Reeves(University of California San Diego), Eugene Golts(University of California San Diego), Ramon Sanchez(University of San Diego), Laith Alshawabkeh(UC San Diego Health System), Gordon Yung(University of California System), John J. Nigro(Creighton University), Howaida El‐Said(University of California San Diego), Yuko Kono(University of San Diego), Kristin L. Mekeel(University of San Diego), Christine M. Lin(University of California System), Pranab Barman(University of San Diego), Aleah L. Brubaker(University of San Diego), Jennifer Berumen(University of San Diego), Paul Kim(Profectus Biosciences (United States)), Deborah Raleigh, Justin Parekh(University of California San Diego), Eric Adler(University of California San Diego), Amanda Topik(University of California San Diego)
Cited by 1
Related Papers
Survivin and molecular pathogenesis of colorectal cancer
|The Lancet|2003|322
A prospective study on the prevalence of NAFLD, advanced fibrosis, cirrhosis and hepatocellular carcinoma in people with type 2 diabetes
|Journal of Hepatology|2022|310
Inhibition of melanoma tumor growth <i>in vivo</i> by survivin targeting
|Proceedings of the National Academy of Sciences|2001|285
TVB-2640 (FASN Inhibitor) for the Treatment of Nonalcoholic Steatohepatitis: FASCINATE-1, a Randomized, Placebo-Controlled Phase 2a Trial
|Gastroenterology|2021|216
Transgenic expression of survivin in keratinocytes counteracts UVB-induced apoptosis and cooperates with loss of p53
|Journal of Clinical Investigation|2001|194